Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.00
Ask: 34.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.25%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 33.00
TPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to Share Purchase Agreements

8 Sep 2020 07:01

RNS Number : 2840Y
Panoply Holdings PLC (The)
08 September 2020
 

8 September 2020

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Amendment to Share Purchase Agreements

 

The Panoply (AIM: TPX), the technology-enabled services group focused on digital transformation, announces that the Group has entered into various agreements to amend the terms of a number of its historical share purchase agreements ("SPA"). The details of these amendments are set out below.

 

In line with the Group's strategy, as announced in its recent Annual Report, to consolidate its end-to-end propositions under two full stack brands, The Panoply has agreed to accelerate the end of the earn-out periods in respect of FutureGov and Ameo with a view facilitating full integration into the Group. Ameo is becoming part of FutureGov, supercharging its change delivery and opening new doors within local and central Government for even bigger impact. Ameo supports its clients through full stack change delivery to build the best outcomes for citizens with long term impact. Both Ameo and FutureGov continue to trade strongly in line with expectations.

 

The result of these changes, together with the other amendments detailed below, is to increase the total deferred consideration now known to be payable by The Panoply to £20,835,794. The maximum further shares to be issued as a result of this consideration is 26,395,283, which reduces to 18,719,658 assuming the share price remained constant at 130p, being the closing mid market price on the day prior to this announcement.

 

SPA for the acquisition of the entire issued share capital of FutureGov Ltd ("FG") dated 11 June 2019 (the "FG SPA") 

The parties to the FG SPA have agreed that the FG sellers will receive deferred earn-out consideration equal to a fixed amount of £1,249,290 in respect of the 12 month period ending on 31 March 2021.

 

The FG SPA has been amended so that this amount is to be paid in substitution for amounts that were previously to have been determined by a calculation that was predominantly based on FG's EBITDA performance for the period to 31 March 2021 ("FG Reference Period").  Otherwise the terms of the original FG SPA are not substantially changed, including in respect of the proportion of consideration payable as ordinary shares in the Panoply (96%) ("Panoply Shares") and cash (4%).

 

Further, the number of Panoply Shares to be issued and allotted continues to be calculated by dividing the earn-out price payable by the greater of 83.125 pence and the volume-weighted average mid-market price ("VWAP") over the 30 business days prior to the issue of the relevant Panoply Shares. The timing of the issue and allotment of these Panoply Shares also remains unchanged, being in four tranches following the publication of the accounts of the Panoply for the relevant FG Reference Period.

 

The cash element of the deferred earn-out consideration, being £121,136.40, will be paid by the Panoply within 10 business days of this announcement. 

 

SPA for the acquisition of the entire issued share capital of AMEO Professional Services Limited ("Ameo") dated 10 March 2020 (the "Ameo SPA")

 

The parties to the Ameo SPA have agreed that the Ameo sellers will receive deferred earn-out consideration equal to fixed amounts of: 

 

1. £416,460 in respect of the 17 month period ending on 31 March 2021 and; 

2. £889,710 in respect of the 12 month period ending on 31 March 2022.

 

The Ameo SPA has been amended so that these amounts are to be paid in substitution for amounts that were previously to have been determined by a calculation that was predominantly based on Ameo's EBITDA performance for each of these periods (each an "Ameo Reference Period"). Otherwise the terms of the Ameo SPA are not substantially changed and the number of Panoply Shares to be issued and allotted remains calculated by dividing the earn-out price payable by  the greater of 82 pence and the VWAP over the 30 business days prior to the issue of the relevant Panoply Shares. The timing of the issue and allotment of these Panoply Shares also remains unchanged, being in one tranche following the publication of the Panoply's accounts for the relevant Ameo Reference Period. 

 

SPA for the acquisition of the entire issued share capital of Greenshoot Labs Limited ("GSL") dated 11 February 2019 (the "GSL SPA")

 

The parties to the GSL SPA have agreed that the GSL sellers will receive deferred earn-out consideration equal to a fixed amount of £500,000 in respect of the 12 month period ending on 31 March 2020 (the "First GSL Reference Period"), in substitution for an amount that would have been previously determined by a calculation predominantly based on GSL's EBITDA performance for the First GSL Reference Period. This is to reflect the value of GSL's revenue growth during the period.

 

The calculation for the amount of deferred earn-out consideration in respect of the 12 month period ending on 31 March 2021 (the "Second GSL Reference Period") will remain based on the financial performance of GSL for the Second GSL Reference Period. In addition, the GSL deferred earn-out consideration remains payable by the Panoply by the issue of the relevant number of Panoply Shares (calculated in accordance with the GSL SPA) in one tranche following the publication of the Panoply's accounts for the First and Second GSL Reference Period (as applicable).

 

SPA for the acquisition of the entire issued share capital of Deeson Group Holdings Limited ("DGHL") dated 18 December 2018 (the "DGHL SPA")

 

The maximum total amount of consideration that can be payable under the DGHL SPA has been increased to £4,580,000. This a reflection of the strong financial performance of DGHL.

 

Agreement between Neal Gandhi and Maxine Tolfrey 

 

Neal Gandhi ("NG") has entered into an agreement (the "Agreement") with Maxine Tolfrey ("MT") in relation to MT's rights and obligations pursuant to the share purchase agreement for the acquisition of the entire issued share capital of Questers dated 11 May 2018 (the "Questers SPA"). 

 

Pursuant to the Agreement, MT has agreed that she will transfer to NG any further consideration she may receive pursuant to the Questers SPA. The Agreement has been entered into in compliance with the divorce settlement between NG and MT.

 

Related party transactions

 

The entry into the amendment agreements with the shareholders of FG, Ameo, GSL and DGHL each constitute related party transactions under the AIM Rules for Companies. The Directors of The Panoply (who are all independent in relation to these matters), having consulted with Stifel, consider that the terms of those various amendment agreements are fair and reasonable insofar as the Group's shareholders are concerned.

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

Fred Walsh

Alex Price

 

 

Via Alma PR

 

 

+44 (0)207 710 7600

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44(0)203 405 0209

 

 

 

 

About The Panoply

 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

 

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c. 70% of its client base representing the public sector and c. 30% representing the commercial sector.

 

More information is available at www.thepanoply.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAANXEENEEAA
Date   Source Headline
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m
14th Sep 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th Sep 20231:05 pmRNSUpdate on Current Trading and Notice of AGM
25th Aug 20231:03 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.